Nancy Wexler spent forty years studying Huntington's disease, a fatal neurological condition that runs in families and killed her mother. Her research at Columbia University became foundational to understanding the disease's genetic basis. In 1986, scientists used her work to locate the Huntington's gene, one of the first major successes in modern genetic mapping.
That breakthrough made genetic testing possible. People could now learn whether they carried the mutation that causes Huntington's, typically triggering symptoms in midlife. The test offered clarity about their future, though not prevention or cure.
Wexler never took it.
For decades, she chose not to know her status. Despite creating the very science that enabled the test, she lived with uncertainty about whether she would develop the disease. Colleagues found this puzzling. Here was a researcher who had devoted her career to unraveling Huntington's genetics, yet she refused to use the tool her work had made available.
Wexler's decision reflects a deeper tension in genetic medicine. Knowledge about disease risk doesn't always translate to better health outcomes or peace of mind. Some people find knowing their genetic status paralyzing rather than empowering. Others worry that a positive result would define their identity and limit their opportunities, regardless of when or if symptoms appear.
Her choice also highlights the gap between scientific possibility and human psychology. The ability to test for a gene doesn't obligate anyone to undergo that test. Wexler understood the science intimately. She also understood herself well enough to know that knowing might constrain her life more than help it.
Wexler eventually took the test at age eighty, learning she carries the Huntington's mutation. But for most of her working life, she prioritized living without that knowledge over the scientific clarity it offered. Her decades of work transformed Huntington's research and made genetic testing routine for countless families.